June is a 63-year-old obese female who is only taking glipizide for her type 2 diabetes. She took metformin in the past but made her have diarrhea multiple times a day so she stopped it. Her provider refers her to you to evaluate her to start a GLP-1 receptor agonist.
PMH: H/o stroke, s/p stenting of superior mesenteric and celiac arteries, chronic diarrhea, anxiety disorder, excessive bleeding post-menopausal, hyperlipidemia, gall bladder disease, obesity.
Her labs include: TCHOL 230, LDL 120, HDL 34, TG 250; eGFR 45, A1c has been 9-10% for the past 3 checks; liver function tests are within normal limits.
You decide that the patient is not a good candidate for a GLP-1 receptor agonist. Which of the following patient characteristics lead you to AVOID using a GLP-1 receptor agonist in this patient?
History of ASCVD